Fair Value Calculator Fair Value Calculator
EN DE

PHCAP (PHCAP) Fair Value & Analysis

IN · Market cap ₹2.9B

P PHCAP PHCAP · BSE
Price₹972.10
Fair Value₹183.36
Upside-81.1%
Quality65/100
Watch PHCAP for free — get notified when fair value or trend changes. Watch for free
Evidence: High Range ₹152.08 – ₹229.20

Fair value as of: Jul 5, 2026

From 25 valuation models · updated today

Share price +14.0% over the past month.

Price vs Fair Value (12 months)

₹998.90 ₹172.80 Fair Value ₹183.36 Jul 2025 Jul 2026

12‑month range ₹172.80 – ₹998.90 · fair‑value band ₹152.08 – ₹229.20 · the ₹972.10 price screens above the ₹183.36 fair value. As of Jul 5, 2026.

✦ Which stocks are undervalued right now? Check free Discover now →

Analysis

PHCAP (PHCAP) currently trades at ₹972.10, while our model-based Fair Value estimate is ₹183.36 — implying the stock looks roughly 81.1% overvalued today. We read business quality at 65/100 (solid quality). Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: high).

Over the trailing twelve months, PHCAP generated revenue of ₹1.1B at a net margin of 2.9%. Revenue declined 33.7% year over year. It earns a return on equity of 5.8%. Net debt stands at ₹11.1M. Fundamentals as of Jul 5, 2026

Our scenario range runs from ₹152.08 (bear case) to ₹229.20 (bull case); at ₹972.10, the current price sits above that range. The share trades about 3% below its 52-week high, currently above its 200-day average.

Key figures & financial health

Revenue (TTM) ₹1.1B
Revenue growth (YoY) -33.7%
Net margin 2.9%
Return on equity 5.8%
Free cash flow ₹269M FY2026
P/E ratio 90.1
More key figures
Operating margin -11.1%
EPS (TTM) ₹10.79
EPS growth (YoY) -92.0%
Net debt ₹11.1M FY2020

Figures from reported company fundamentals (EODHD) · as of Jul 5, 2026. TTM = trailing twelve months.

Revenue & earnings trend

FY2022 – FY2026 · reported fiscal years

PHCAP reported revenue of ₹1.1B in FY2026 versus ₹832M in FY2022, a compound +7.9%/yr. Reported net income was ₹32.4M in FY2026, compounding −27.3%/yr from FY2022.

Revenue +7.9%/yr
FY22 ₹832M
FY23 ₹761M
FY24 ₹1.6B
FY25 ₹1.9B
FY26 ₹1.1B
Net income −27.3%/yr
FY22 ₹116M
FY23 −₹37.6M
FY24 ₹201M
FY25 ₹78.5M
FY26 ₹32.4M

Is PHCAP fairly valued? → Check now

🧮 Run the numbers yourself — free valuation calculators
📤 Share or link this analysis
🔗 Embed on your site (free fair-value badge)

Paste this into your site or blog — it shows the current fair value and links back here (free, and welcome):

Cite: Fair Value Calculator (2026). "PHCAP Fair Value". https://www.fairvalue-calculator.com/stock/PHCAP

Explore undervalued stocks

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued Blue-Chip StocksUndervalued Small-Cap Stocks

Frequently asked questions

Is PHCAP (PHCAP) undervalued?
As of Jul 5, 2026, our model estimates a fair value of ₹183.36 versus a price of ₹972.10 — about −81% (overvalued). Model-based estimate, not financial advice.
What is the fair value of PHCAP?
Our model-based fair value for PHCAP is ₹183.36 (as of Jul 5, 2026), built from audited fundamentals. The current price is ₹972.10.
What is the quality score of PHCAP?
PHCAP has a Quality Score of 65/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.
What is the revenue of PHCAP (PHCAP)?
PHCAP reported trailing-twelve-month revenue of about ₹1.1B (latest available figure, as of Jul 5, 2026).
What is the net profit margin of PHCAP?
The net profit margin of PHCAP is about 2.9%, meaning it keeps roughly 2.9% of revenue as net income. Based on the latest reported figures.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.